← All trials
NCT01501487
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 1, 2011
- Primary completion
- Feb 1, 2016
- Completion date
- Jun 1, 2017
- First posted
- —
- Last posted
- —
- Enrollment
- 226
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- AgendiaLead sponsor
- University of South FloridaOverall official - principal investigator
- University of South FloridaCollaborator
- University of MiamiCollaborator
- Morton Plant Mease Health CareCollaborator
- University of OklahomaCollaborator
- University of South AlabamaCollaborator
- Advent HealthCollaborator
- Plano Cancer CenterCollaborator
- Ohio State UniversityCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.